Co-Delivery of Dihydroartemisinin and Indocyanine Green by Metal-Organic Framework-Based Vehicles for Combination Treatment of Hepatic Carcinoma

• Autors principals: Yang Chen (Autor), Bin Wang (Autor), Wenping Chen (Autor), Tao Wang (Autor), Min Li (Autor), Zucheng Shen (Autor), Fang Wang (Autor), Jing Jia (Autor), Fenglan Li (Autor), Xiangyu Huang (Autor), Junyang Zhuang (Autor), Ning Li (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2022-09-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Dihydroartemisinin (DHA), a widely used antimalarial agent, has clinical potential for the treatment of hepatic carcinoma. Although chemotherapy is indispensable for tumor therapy, it is generally limited by poor solubility, low efficiency, rapid clearance, and side effects. As an emerging treatment...